FR2357254A1 - Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer - Google Patents

Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer

Info

Publication number
FR2357254A1
FR2357254A1 FR7720612A FR7720612A FR2357254A1 FR 2357254 A1 FR2357254 A1 FR 2357254A1 FR 7720612 A FR7720612 A FR 7720612A FR 7720612 A FR7720612 A FR 7720612A FR 2357254 A1 FR2357254 A1 FR 2357254A1
Authority
FR
France
Prior art keywords
compsn
ascorbic acid
pref
delayed
prolonged release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7720612A
Other languages
English (en)
Other versions
FR2357254B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BROSCHEK G CHEM PROD GEBRO
Original Assignee
BROSCHEK G CHEM PROD GEBRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BROSCHEK G CHEM PROD GEBRO filed Critical BROSCHEK G CHEM PROD GEBRO
Publication of FR2357254A1 publication Critical patent/FR2357254A1/fr
Application granted granted Critical
Publication of FR2357254B1 publication Critical patent/FR2357254B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/16Fluorine compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • A61K8/21Fluorides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une préparation pharmaceutique pour le traitement de l'ostéoporose. Ladite préparation contient comme agents actifs : a. Un fluorure (sel) soluble (NaF, KF); et b. De l'acide ascorbique -L et /ou de sels alcalins ou alcalino-terreux de cet acide Les constituants a et b sont utilisés dans un rapport molaire de 1 : 0,5 à 1 : 5,0. La préparation est présentée de préférence sous forme d'un composé à action retardée en deux étapes. Application à l'abaissement de la dose de fluorure à une valeur ne provoquant pas de douleurs périostales.
FR7720612A 1976-07-06 1977-07-05 Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer Granted FR2357254A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762630326 DE2630326C2 (de) 1976-07-06 1976-07-06 Präparat zur Behandlung der Osteoporose und seine Herstellung

Publications (2)

Publication Number Publication Date
FR2357254A1 true FR2357254A1 (fr) 1978-02-03
FR2357254B1 FR2357254B1 (fr) 1981-09-11

Family

ID=5982328

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720612A Granted FR2357254A1 (fr) 1976-07-06 1977-07-05 Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer

Country Status (4)

Country Link
AT (1) AT364716B (fr)
BE (1) BE856458A (fr)
DE (1) DE2630326C2 (fr)
FR (1) FR2357254A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604360A1 (fr) * 1986-09-25 1988-04-01 Colgate Palmolive Co Medicament a liberation controlee pour fournir des ions fluorure

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343253A1 (de) * 1983-08-11 1985-02-21 Neill Bailey San Antonio Tex. Walsdorf Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604360A1 (fr) * 1986-09-25 1988-04-01 Colgate Palmolive Co Medicament a liberation controlee pour fournir des ions fluorure
NL8702297A (nl) * 1986-09-25 1988-04-18 Colgate Palmolive Co Medicament voor het verschaffen van fluoride-ionen voor de behandeling en preventie van met botverlies gepaardgaande ziekten.
BE1000159A5 (fr) * 1986-09-25 1988-06-28 Colgate Palmolive Co Medicament a liberation controlee pour fournir des ions fluorure.

Also Published As

Publication number Publication date
BE856458A (fr) 1977-10-31
FR2357254B1 (fr) 1981-09-11
AT364716B (de) 1981-11-10
ATA485577A (de) 1981-04-15
DE2630326C2 (de) 1983-07-21
DE2630326A1 (de) 1978-01-12

Similar Documents

Publication Publication Date Title
MXPA02011942A (es) Composiciones, equipos y metodos para estimular beneficios definidos para la salud.
Neuman et al. Synthetic hydroxyapatite crystals: IV. Magnesium incorporation
ES8502873A1 (es) Metodo de preparacion de soluciones para dialisis.
AU3981089A (en) Salt product and method for its preparation
LTIP1472A (en) Composition of priming hard tissue of tooth
KR870008580A (ko) 항치석 치약
JPS6333321A (ja) 口腔組成物
IL75536A0 (en) Pseudomonic acid salt,its preparation and pharmaceutical and veterinary compositions comprising it
MY101750A (en) Improvements in or relating to calcium salts.
EA200001191A1 (ru) Новые фармацевтические композиции для лечения и жизнеобеспечения (поддержания жизненных функций) и способ их приготовления
ES510245A0 (es) "un metodo para obtener una preparacion de insulina".
FR2357254A1 (fr) Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
GB2272375A (en) Pharmaceutical composition
ES364982A1 (es) Un procedimiento para la elaboracion de un preparado de hierro oral.
AU2908189A (en) Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases
IL41412A (en) Mineral salt preparation
CA2001123A1 (fr) Traitement de l'osteoporose
GB1501096A (en) Methods and pharmaceutical preparation for the treatment of hypercholesterolaemia
SE7602359L (sv) Aluminiumpolyhydroxisulfat-hydrat
JPS63141921A (ja) 口腔用組成物
GB1221633A (en) Compositions for hardening teeth and bones
RU2002116377A (ru) Жидкие лечебные составы для внутривенного введения, содержащие декстрозу и инсулин
HU213872B (en) Oligo- and polygalacturonate mixed complex, pharmaceutical and food compositions containing them, further process for preparing these compounds
DE3362246D1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle

Legal Events

Date Code Title Description
ST Notification of lapse